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Filoviruses belong to the order of negative-stranded non-segmented RNA viruses and are classified into two genera, Ebola and Marburg
viruses. They have a characteristic filamentous shape, which is largely determined by the matrix protein VP40. Although VP40 is the main driving
force for assembly and budding from the host cell, the production of infectious virus involves an intricate interplay between all viral structural
proteins in addition to cellular factors, e.g., those that normally function in multi-vesicular body biogenesis. As a consequence, assembly and
budding steps are defined to specific cellular compartments, and the recent progress in understanding how the different components are assembled
into stable enveloped virus particles is reviewed.
D 2005 Elsevier Inc. All rights reserved.
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Filoviruses are the causative agent of a severe, mostly fatal
hemorraghic fever in humans. The route of transmission
involves direct contact with body fluids from either infected
patients or non-human primates or contact with a to date
unknown natural host (Feldmann et al., 2003, 2004). Filo-
viruses contain a single-stranded negative-sense RNA genome,
which displays a genome organization similar to the other0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Paramyxoviridae, Rhabdoviridae and Bornaviridae. The 19-
kb large filovirus genome encodes the structural proteins NP
(major nucleoprotein), VP35 (P-like protein), VP40 (matrix
protein), GP (glycoprotein) VP30 (minor nucleoprotein), VP24
and L (RNA-dependent RNA polymerase). Both VP30 and
VP24 are unique to the Filoviridae (Feldmann and Kiley,
1999). Although all of the structural information to build a viral
particle is encoded in the viral genome, a huge body of recent
work has shown that filoviruses like other enveloped viruses
such as HIV-1 hijack cellular protein machines in order to
mediate assembly at and budding from cellular membranes
(Morita and Sundquist, 2004; Schmitt and Lamb, 2004).06) 64 – 70
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The matrix protein VP40 is the major structural protein
(Geisbert and Jahrling, 1995). Numerous studies have shown
that expression of VP40 in mammalian cells leads to the
production of virus-like particles (VLPs) with filamentous
morphology suggesting that VP40 contains the necessary
information for particle assembly and budding. However,
VP40 containing VLPs vary in diameter (40 to 80 nm),
compared to a strict diameter of ¨80 nm of infectious virus,
indicating that other viral components such as the nucleocap-
sids determine the final particle morphology (Bavari et al.,
2002; Harty et al., 2000; Hoenen et al., 2005; Jasenosky et al.,
2001; Kolesnikova et al., 2004a; Noda et al., 2002; Swenson et
al., 2004; Timmins et al., 2001). Structural and functional
studies have shown that VP40 adopts different conformations
in vitro that have been partially linked to different functions.
VP40 is initially expressed as monomer, which folds into two
structurally related beta sandwich domains forming a closed
conformation (Dessen et al., 2000). The N-terminal domain
constitutes the oligomerization module, which allows the
formation of hexameric and octameric ring-like structures
(Ruigrok et al., 2000; Timmins et al., 2003a). The C-terminal
domain was found to be required for membrane interaction
(Jasenosky et al., 2001; Ruigrok et al., 2000; Timmins et al.,
2001). Oligomerization is achieved by the displacement of the
C-terminal domain form the N-terminal domain underlining the
metastable conformation of monomeric VP40. In vitro mem-
brane targeting experiments suggest that lipid bilayer interac-
tion may be the trigger for the conformational change
(Scianimanico et al., 2000). Electron microscopy and molec-
ular modeling indicate that hexamer formation involves the
interface, which is otherwise occupied by the C-terminal
domain in the closed conformation, which extends via a
flexible linker from the ring-like structures and thus allows
membrane interaction (Dessen et al., 2000; Nguyen et al.,
2005; Scianimanico et al., 2000; Timmins et al., 2003a). In
contrast to the hexameric form of VP40, the octameric ring-like
structure depends on the interaction with single-stranded RNA.
The octamer is formed by four anti-parallel homodimers of the
N-terminal domain that bind two RNA triribonucleotides
containing the sequence 5V-U-G-A-3V at the center of the pore.
The bound RNA stabilizes the dimer–dimer interactions, and
biochemical studies show that RNA interaction plays a crucial
structural role as no octamers can be formed in the absence of
RNA (Gomis-Ru¨th et al., 2003; Timmins et al., 2003a). It is not
known whether octameric VP40 binds viral or cellular RNA
during infection. It thus remains unclear whether RNA binding
has a sole structural role to generate octamers for a specific
function, or this function is connected to the viral RNA
metabolism. Mutagenesis studies have shown that RNA
binding and thus octamer formation is absolutely essential for
virus replication (Hoenen et al., 2005). Although VP40
octamers are efficiently incorporated into VP40 containing
VLPs (Hoenen et al., 2005; Panchal et al., 2003), the inhibition
of octamer formation still produces VP40 containing VLPs that
are indistinguishable from VLPs containing wild type VP40(Hoenen et al., 2005). On the other hand, no VP40 octamers
can be detected in infectious Ebola virus particles by Western
blot analysis (Gomis-Ru¨th et al., 2003). Therefore, the precise
function of VP40 octamers stays unclear. They might play a
role in RNP formation as described for a number of matrix
proteins (Coronel et al., 2001; Kaptur et al., 1991; Schmitt et
al., 2002; Stricker et al., 1994). Such a function is in agreement
with the association of VP40 with Marburg virus RNPs present
in inclusion bodies (Kolesnikova et al., 2002). The three
different conformations of VP40 are thus prime examples of
how viral genomes with a limited capacity can encode for
protein conformations that probably exert different tasks.
However, the oligomeric or polymeric form of VP40 within
viral particles still remains elusive.
Cellular factors implicated in enveloped virus budding
HIV-1 Gag deletions and mutational analyses revealed
sequence motifs that are absolutely required for budding
(Go¨ttlinger et al., 1991; Huang et al., 1995; Wills et al.,
1994). These motifs were termed late domains since they affect
a late step in budding (Parent et al., 1995). Since then, a
number of late domain sequences including PT/SAP, PPxY and
YP(X)nL have been described to function in both positive - and
negative-strand RNA virus assembly and budding (Morita and
Sundquist, 2004; Schmitt and Lamb, 2004). Late domains can
be functionally interchangeable, their position within the viral
protein can vary, and they can act in trans although some
context dependency is conserved (Martin-Serrano et al., 2004;
Morita and Sundquist, 2004).
Numerous recent studies show that the late domains serve as
entry points into a network of proteins that normally functions
in multi-vesicular body (MVB) biogenesis. The protein
network involved in MVB formation was first identified in
Saccharomyces cerevisiae and implicated in membrane protein
trafficking from the Golgi and plasma membranes via the
endosomal system to the lysosome for degradation. Receptor
ubiquitinylation serves as a signal for the protein transport to
endosomal membrane microdomains, which ultimately leads to
membrane invagination and vesicle budding into endosomal
structures (multi-vesicular bodies), thus delivering the cargo
from the limiting membrane of the endosome into the lumen of
the organelle. This process is mediated by non-essential
proteins known as class E Vps proteins in S. cerevisiae
(Gruenberg and Stenmark, 2004; Katzmann et al., 2002).
Briefly, initial recognition of the ubiquitinylated cargo leads
to endocytosis and interaction with class E proteins Hrs
(Vps27p) and Stam (Katzmann et al., 2003) that in turn recruits
the ESCRT-1 (Endosomal Sorting Complex Required for
Transport) complex composed of Vps23p/Tsg101, Vps28p and
Vps37p to the endosomal membrane (Bache et al., 2003;
Katzmann et al., 2001; Lu et al., 2003). In yeast ESCRT-I cargo
recognition then induces the formation of ESCRT-II (Babst et al.,
2002b), which activates the assembly of the ESCRT-III multi-
protein complexes that are composed of CHMP (CHarged
Multivesicular body Protein) family proteins (Babst et al.,
2002a). Finally, the activity of the AAA-type ATPase Vps4 is
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membranes (Babst et al., 1998, 2002a). Studies with mutant
Vps4 and CHMP fusion proteins revealed a late budding arrest
of fully assembled virus particles suggesting that ESCRT-III and
Vps4 functions are crucial for enveloped virus release (Licata et
al., 2003; Lin et al., 2005; Martin-Serrano et al., 2003; Strack et
al., 2003; von Schwedler et al., 2003).
Notably, the first identified late domain motif PTAP was
shown to bind to the cellular factor Tsg101 (ESCRT-I), which
also binds ubiquitin (Demirov et al., 2002; Garrus et al., 2001;
Sundquist et al., 2004; VerPlank et al., 2001). Similarly, a
second late domain motif, YP(X)nL mediates binding to ALIX/
AIP1 that itself interacts directly with Tsg101 via its own PTAP
motif (Strack et al., 2003; von Schwedler et al., 2003). The
third late domain motif PPxY mediates interactions with
proteins that contain WW domains, such as ubiquitin ligases
(E3 enzyme). It was long speculated that ubiquitin plays a role
in assembly and budding since ubiquitin is incorporated into
retroviral particles (Ott et al., 1998; Putterman et al., 1990),
Gag proteins are monoubiquitinylated (Ott et al., 2000), and
protease inhibitors inhibit virus budding (Patnaik et al., 2000;
Schubert et al., 2000; Strack et al., 2000). For more detailed
recent reviews on cellular factors implicated in virus assembly
and budding, see Morita and Sundquist (2004) and the article
by Bieniasz and colleagues in this issue.
VP40 interaction with cellular factors
Ebola virus VP40 contains two overlapping late domains 7-
PTAPPEY-13 while Marburg virus VP40 contains only the
putative functional, 16-PPPY-19 motif (Morita and Sundquist,
2004; Schmitt and Lamb, 2004). Ebola virus VP40was shown to
interact with Tsg101 via its PTAP motif in vivo (Martin-Serrano
et al., 2001) and in vitro with both monomeric and oligomeric
VP40 (Timmins et al., 2003b). Mammalian co-expression of
Tsg101 and VP40 indicated that VP40 recruits Tsg101 to the
plasma membrane and thus to the site of budding (Martin-
Serrano et al., 2001) which includes VP40 lipid raft localization
(Bavari et al., 2002; Panchal et al., 2003; Licata et al., 2003). In
addition, Tsg101 is incorporated into VP40 containing VLPs
(Licata et al., 2003). Tsg101 recruitment most likely includes
ESCRT-I assembly at the site of budding (Martin-Serrano et al.,
2003b; Stuchell et al., 2004; Tanzi et al., 2003) consistent with
the finding that a C-terminal truncation of Tsg101 exerts a
dominant negative effect on VP40 VLP formation (Yasuda et al.,
2003). Similarly, the downstream partners, including ESCRT-
III, are probably also recruited as a mutant Vps4 ATPase affects
VP40 VLP formation similar as in case of retrovirus budding
(Licata et al., 2003; Martin-Serrano et al., 2003a; Strack et al.,
2003; von Schwedler et al., 2003).
The importance of the second motif PPPY was first
recognized by studies that showed VP40 binding to a WW
domain from the yeast E3 ligase Rsp5 (Nedd4 homologue) and
VP40 ubiquitinylation in vitro. These experiment thus revealed
a role for the late domain in VP40 release from mammalian
cells (Harty et al., 2000). The PPEY motif was since shown to
interact with WW domain 3 from human Nedd4 in vitro, whichrequires the oligomeric ring-like conformation of VP40
(Timmins et al., 2003b). This indicates that ubiquitinylation
by an E3 ligase may act on an activated conformation of VP40
that is most likely targeted to the lipid bilayer via its C-terminal
domain, which is in agreement with the plasma membrane
targeting of HECT domain containing E3 ligases via their C2
domains. Consistent with the in vitro data, dominant negative
mutants of Nedd4 inhibit budding of VP40 containing VLPs
(Yasuda et al., 2003). Recently, other HECT domain containing
ubiquitin ligases were implicated in the PPPY late domain
interaction including WWP1, WWP2 and itch (Martin-Serrano
et al., 2005). In addition, the recruitment of HECT domain
containing E3 ligases including Nedd4 into aberrant endosomal
compartments induced by mutant Vps4 provides a direct link
between the function of class E Vps factors and ubiquitinyla-
tion (Martin-Serrano et al., 2005). Such a link is also consistent
with the implication of yeast Rsp5 in ubiquitinylation of cargo
for sorting into MVB and the genetic linkage of Rsp5 and
ESCRT-III (Katzmann et al., 2004). Therefore, the presence of
a single PPxY motif in Marburg virus VP40 may be sufficient
to recruit the Vps machinery for assistance in assembly and
budding.
A number of studies have shown that the presence of intact
late domains is required for the efficient release of VP40
containing VLPs albeit some VP40 release takes place in the
absence of late domains (Harty et al., 2000; Jasenosky et al.,
2001; Timmins et al., 2001). In addition, recent work shows
that the Ebola virus VP40 late domains are not absolutely
required for virion production in cell culture, although titers of
late domain mutant virions were affected by one log unit
(Neumann et al., 2005). This thus poses the question as to
whether yet other unknown sequences in VP40 are implicated
in the assembly and budding process.
Cellular transport of VP40
Since expression of VP40 reveals mostly plasma mem-
brane targeting (Bavari et al., 2002; Harty et al., 2000;
Hoenen et al., 2005; Martin-Serrano et al., 2001; Timmins et
al., 2001), which includes lipid raft microdomain localization
(Bavari et al., 2002; Panchal et al., 2003), an active transport
of VP40 to specific cellular sites is required. In addition,
ultrastructural analyses of VP40 in Ebola virus and Marburg
virus-infected cells detect VP40 in viral inclusions and in
multi-vesicular bodies (MVBs) derived from the late endoso-
mal compartment indicating (i) an interaction of VP40 with
nucleocapsid structures and (ii) with endosomal membranes
(Geisbert and Jahrling, 1995; Kolesnikova et al., 2002,
2004a). It has been thus suggested that VP40 is transported
through the retrograde late endosomal pathway en route from
the endosome to the plasma membrane (Kolesnikova et al.,
2002, 2004a, 2004b).
The role of the glycoprotein GP in assembly and budding
The envelope of filoviruses is decorated by the trimeric
surface protein GP, a type I transmembrane protein (Feldmann
B. Hartlieb, W. Weissenhorn / Virology 344 (2006) 64–70 67et al., 1991), which mediates cell entry (Schibli and Weissen-
horn, 2004). GP is initially expressed as a precursor protein that
is subsequently cleaved by the subtilisin-like proprotein
convertase furin in the TGN into two subunits, the receptor
binding domain GP1 and the membrane anchored fusion
protein GP2 (Volchkov et al., 1998a, 2000). Two C-terminal
cysteins between the transmembrane region and the short
cytoplasmic region are acylated (Funke et al., 1995; Ito et al.,
2001), which may play a role in a postulated interaction with
the matrix protein VP40. GP expression alone leads to its
transport to the plasma membrane via the secretory pathway
and to the release of GP containing vesicles (Kolesnikova et al.,
2004b; Sa¨nger et al., 2001; Volchkov et al., 1998b). However,
upon co-expression of GP and VP40 alone or in Marburg virus-
infected cells, GP re-localizes to MVBs, which are also
enriched in VP40. This suggests that GP and VP40 are
transported together to the site of budding at the plasma
membrane. In addition, such a co-localization is also consistent
with virus budding into endosomal structures (Kolesnikova et
al., 2004b). Like VP40, GP is targeted to lipid raft micro-
domains in the plasma membrane, and co-expression of VP40
and GP supports and enhances the efficiency of VP40 and GP
containing VLP formation, which is morphologically indistin-
guishable from infectious Ebola virus (Bavari et al., 2002;
Noda et al., 2002). Interestingly, VLPs containing VP40 and
GP have been shown to provide protection from filovirus
infection upon VLP immunization (Warfield et al., 2003;
Warfield et al., 2004).
Assembly of the nucleocapsid
The nucleoprotein NP encapsidates the RNA genome
(Sanchez et al., 1992). Expression of NP in insect cells leads
to the formation of helical NP structures that contain cellular
RNA (Mavrakis et al., 2002). Expression of NP in mammalian
cells leads to the formation of intracellular inclusion bodies,Fig. 1. Schematic illustration of distinct transport pathways of viral components to th
endosomal pathway. (B) Transport of the glycoprotein GP. (C) Transport of nucleo
particles containing NC, VP40 and GP. Both GP and VP40 are targeted to lipid
expression induce either the release of GP containing vesicles or VP40 containing fil
Becker (2004).which are similar to those detected in Ebola and Marburg virus-
infected cells (Becker et al., 1998; Modrof et al., 2002). The
inclusion bodies contain nucleocapsid-like particles that closely
resemble the helical core of nucleocapsids incorporated into
mature virions indicating that NP determines the nucleocapsid
structure (Kolesnikova et al., 2000, 2002; Noda et al., 2005).
Although NP is the major determinant of the nucleocapsid, it
also recruits VP30, VP35 and L into the inclusion bodies
(Becker et al., 1998). In addition, VP24 and VP35 have been
previously implicated in nucleocapsid formation (Huang et al.,
2002). NP was also shown to enhance budding activity of
VP40 suggesting an NP-VP40 interaction (Licata et al., 2004).
Although VP40 interacts with NP containing nucleocapsids,
VP40 and NP do not co-localize in MVBs, indicating that two
different forms or conformations of VP40 pass by the MVB
pathway and associate with nucleocpasids (Kolesnikova et al.,
2004a, 2004b). Although it is currently not known how the
assembled nucleocapsids leave the site of inclusion bodies, it
might involve the cellular cytoskeleton and VP40 interactions
with microtubules (Ruthel et al., 2005). Furthermore, NP is
highly phosphorylated at its C-terminus, which might play a
role in regulating either RNA–protein or protein–protein
interactions (Becker et al., 1994; Elliott et al., 1985).
Although VP24 has been previously implicated in nucleo-
capsid assembly (Huang et al., 2002), its function is not well
understood as nucleocapsid structures can be formed without
VP24 (Watanabe et al., 2004). In addition, Ebola virus VP24
interacts with membranes, oligomerizes and is released from
VP24 expressing cells in form of trypsin-resistant vesicles (Han
et al., 2003). Furthermore, recent studies with Marburg virus
VP24 confirmed its lipid bilayer interaction property and its
oligomerization into tetramers. However, it is also recruited
into viral inclusions containing preformed nucleocapsids as
well as into VP40 containing VLPs. Recruitment of VP24
neither influences efficiency nor morphology of released
particles (Bamberg et al., 2005). Silencing of VP24 by si-e site of assembly and budding. (A) Transport of VP40 along the retrograde late
cpasids (NC containing NP, VP30, VP35, L and VP24) and assembly of viral
raft microdomains (LR) that serve as platforms for assembly. GP and VP40
amentous VLPs (shaded areas). The figure was modified from Kolesnikova and
B. Hartlieb, W. Weissenhorn / Virology 344 (2006) 64–7068RNA in Marburg virus-infected cells resulted in reduction of
released virions, indicating a role in assembly and/or budding,
whereas viral transcription and replication were not affected
(Bamberg et al., 2005). Accordingly, VP24 might be either
important for the assembly of transport competent nucleocap-
sids or the association of nucleocapsids with the transport
machinery or in the targeting of the nucleocapsids to the
budding sites containing GP and VP40 (Bamberg et al., 2005;
Kolesnikova et al., 2004b).
Conclusions
The matrix protein VP40 is initially expressed in a
monomeric conformation that is targeted to cellular mem-
branes. This may include recruitment of cellular factors such as
Tsg101 to the membrane or vice versa and ubiquitinylation of
membrane associated VP40 by HECT domain containing
ubiquitin ligases. Transport to the plasma membrane occurs
by the retrograde late endosomal pathway via MVBs. VP40
expression alone then leads to the targeting to lipid raft
microdomains and the release of filamentous VLPs. VP40 is
thus sufficient to re-localize the cellular budding machinery via
Tsg101 and HECT domain containing ubiquitin ligase interac-
tions to the site of virus assembly and budding. VP40 is also
found in association with viral inclusions containing assembled
nucleocapsids, probably in a conformation different from the
monomeric form such as the hexameric form or the octamers in
complex with RNA (Fig. 1A).
GP expression follows the regular secretory pathway and
leads to lipid raft microdomain localization of GP. Surprisingly,
this is sufficient for the release of GP containing vesicles (Fig.
1B). However, upon co-expression of GP and VP40 and in
Marburg virus-infected cells, GP localizes to the late endosome
after proteolytic cleavage in the TGN and accumulates in
MVBs together with VP40. Both are thus co-transported to the
site of assembly and budding (Fig. 1C). NP–RNA interactions
are sufficient for nucleocapsid assembly that recruits VP30,
VP35 and L. Nucleocapsids accumulate in cellular inclusions
that co-localize with small amounts of VP40. These complexes
are then transported to VP40 and GP containing MVBs and to
the plasma membrane that leads to virus particle assembly and
release (Fig. 1C).
There are most likely a number of features common to
assembly and budding processes of enveloped viruses since
most enveloped viruses recruit cellular factors that normally
act in MVB biogenesis. Based on the available data, we
hypothesize that recruitment of cellular factors serves
potentially two major purposes. Firstly, it needs to recruit
factors that help to initiate the assembly process mediated by
the matrix protein, which probably includes initiation of
membrane curvature at the site of assembly. Such a function
may be recruited by the ubiquitinylation of matrix proteins, a
process which is linked to the endocytosis machinery, which
thus may provide such functions. Secondly, recruitment of
ESCRT complexes, especially ESCRT-III and Vps4, may be
required for the last step of the budding process, the release
of the fully assembled virus particle from cellular mem-branes. Therefore, selective employment of cellular proteins
by enveloped viruses via different late domains may provide
specialized fine tuning accessories for the assembly process
and the protein machinery required for final steps in
budding.
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